Altera (ALTR) was the best performer on the S&P 500 Monday following reports the company has reopened negotiations with Intel (INTC). Altera kicked off a rally among chipmakers, including Symantec which helped its shares recover from an earnings-driven sell-off last week. Endo Pharmaceutical (ENDP) lagged the S&P 500 after it agreed to buy privately-held Par Pharmaceutical Holdings to create on the of largest generic drugmakers in the U.S. But it was Apple (AAPL) that headlined the session, gaining more than 1% after activist investor Carl Icahn gave another vote of confidence to the world's largest company.
More from Video
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.